Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.98 USD | -2.68% | +7.88% | +63.15% |
11:49am | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
May. 29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.